Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic HBV Viral Infection

NCT01083251 is registered in ClinicalTrials.gov with Ziv Hospital as lead sponsor.

NCT NCT01083251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01083251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic HBV Viral Infection
Lead sponsor
Ziv Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2010
Completion date
December 31, 2012
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b virus